Connor, Clark & Lunn Investment Management (CC&L)’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $121M | Buy |
1,169,603
+180,842
| +18% | +$16.1M | 0.23% | 96 |
|
|
2026
Q1 | $71M | Buy |
988,761
+933,370
| +1,685% | +$71.9M | 0.16% | 137 |
|
|
2025
Q4 | $4.4M | Buy |
+55,391
| New | +$4.37M | 0.01% | 687 |
|
|
2025
Q3 | – | Sell |
-23,937
| Closed | -$1.65M | – | 1532 |
|
|
2025
Q2 | $1.65M | Buy |
+23,937
| New | +$1.57M | 0.01% | 915 |
|
|
2025
Q1 | – | Sell |
-209,888
| Closed | -$9.42M | – | 1450 |
|
|
2024
Q4 | $9.42M | Buy |
+209,888
| New | +$11.8M | 0.04% | 329 |
|
|
2024
Q2 | – | Sell |
-9,660
| Closed | -$770K | – | 1442 |
|
|
2024
Q1 | $770K | Buy |
+9,660
| New | +$738K | ﹤0.01% | 966 |
|
|
2023
Q2 | – | Sell |
-46,750
| Closed | -$3.47M | – | 1349 |
|
|
2023
Q1 | $3.47M | Sell |
46,750
-166,443
| -78% | -$14M | 0.02% | 438 |
|
|
2022
Q4 | $19.9M | Sell |
213,193
-113,787
| -35% | -$11M | 0.11% | 136 |
|
|
2022
Q3 | $31.2M | Buy |
326,980
+71,511
| +28% | +$7.08M | 0.2% | 84 |
|
|
2022
Q2 | $23.7M | Sell |
255,469
-9,071
| -3% | -$885K | 0.14% | 113 |
|
|
2022
Q1 | $26.8M | Buy |
+264,540
| New | +$27.8M | 0.13% | 126 |
|
|
2021
Q4 | – | Sell |
-2,365
| Closed | -$201K | – | 1104 |
|
|
2021
Q3 | $201K | Sell |
2,365
-237,957
| -99% | -$19.9M | ﹤0.01% | 948 |
|
|
2021
Q2 | $20.1M | Buy |
240,322
+35,299
| +17% | +$2.89M | 0.1% | 174 |
|
|
2021
Q1 | $15.4M | Buy |
+205,023
| New | +$14.9M | 0.09% | 177 |
|
|
2020
Q4 | – | Sell |
-171,211
| Closed | -$10M | – | 922 |
|
|
2020
Q3 | $10M | Sell |
171,211
-203,524
| -54% | -$12.7M | 0.07% | 197 |
|
|
2020
Q2 | $24.3M | Buy |
374,735
+28,296
| +8% | +$1.78M | 0.17% | 105 |
|
|
2020
Q1 | $20.6M | Buy |
346,439
+241,830
| +231% | +$16.1M | 0.18% | 104 |
|
|
2019
Q4 | $7.77M | Buy |
+104,609
| New | +$7.35M | 0.05% | 216 |
|
|
2018
Q3 | – | Sell |
-15,350
| Closed | -$988K | – | 956 |
|
|
2018
Q2 | $988K | Buy |
+15,350
| New | +$1.01M | 0.01% | 618 |
|
|
2017
Q2 | – | Sell |
-180,500
| Closed | -$14.2M | – | 837 |
|
|
2017
Q1 | $14.2M | Sell |
180,500
-182,075
| -50% | -$14.5M | 0.09% | 140 |
|
|
2016
Q4 | $28.6M | Buy |
362,575
+22,250
| +7% | +$1.8M | 0.2% | 92 |
|
|
2016
Q3 | $30.3M | Sell |
340,325
-60,025
| -15% | -$5.67M | 0.21% | 85 |
|
|
2016
Q2 | $38.3M | Buy |
400,350
+53,375
| +15% | +$5.32M | 0.28% | 65 |
|
|
2016
Q1 | $36M | Buy |
346,975
+26,975
| +8% | +$2.62M | 0.28% | 60 |
|
|
2015
Q4 | $31.3M | Buy |
320,000
+3,900
| +1% | +$382K | 0.26% | 64 |
|
|
2015
Q3 | $30.5M | Buy |
316,100
+182,600
| +137% | +$19.2M | 0.25% | 65 |
|
|
2015
Q2 | $14M | Buy |
133,500
+27,600
| +26% | +$2.82M | 0.13% | 91 |
|
|
2015
Q1 | $10.9M | Sell |
105,900
-10,000
| -9% | -$1.01M | 0.09% | 106 |
|
|
2014
Q4 | $11.2M | Sell |
115,900
-33,100
| -22% | -$2.92M | 0.09% | 101 |
|
|
2014
Q3 | $11.9M | Buy |
149,000
+21,900
| +17% | +$1.73M | 0.1% | 97 |
|
|
2014
Q2 | $10.2M | Sell |
127,100
-200
| -0.2% | -$15.1K | 0.07% | 117 |
|
|
2014
Q1 | $10.5M | Buy |
127,300
+25,000
| +24% | +$1.77M | 0.08% | 114 |
|
|
2013
Q4 | $7.78M | Buy |
102,300
+53,325
| +109% | +$3.43M | 0.06% | 121 |
|
|
2013
Q3 | $2.86M | Sell |
48,975
-4,300
| -8% | -$256K | 0.03% | 162 |
|
|
2013
Q2 | $3.21M | Buy |
+53,275
| New | +$3.09M | 0.03% | 146 |
|
Other funds holding CVS
Connor, Clark & Lunn Investment Management (CC&L)'s CVS Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) increased its CVS Health (CVS) stake by 18% in Q2 2026, buying an estimated $16.1M and bringing the position to 1,169,603 shares worth $121M. The position accounts for 0.23% of the portfolio, ranked #96.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CVS in Q2 2013 and has held it in 35 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 1,169,603 shares of CVS Health worth $121M as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) bought 180,842 CVS Health shares in Q2 2026, an estimated $16.1M.
- CVS Health made up 0.23% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #96 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CVS Health in Q2 2013 and has held it in 35 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.